Predict your next investment

Corporation
INDUSTRIAL | Basic Materials / Chemicals
codexis.com

See what CB Insights has to offer

Founded Year

2002

Stage

PIPE | IPO

Total Raised

$92M

Market Cap

2.11B

Stock Price

32.56

About Codexis

Codexis discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services.

Codexis Headquarter Location

200 Penobscot Drive

Redwood City, California, 94063,

United States

650-421-8100

Latest Codexis News

Pharmaceutical Intermediates Market Covid-19 Impact Analysis, Size, Share, Key Trends, Demand and Forecast till 2030

Dec 1, 2021

Pharmaceutical Intermediates Market Covid-19 Impact Analysis, Size, Share, Key Trends, Demand and Forecast till 2030 Future Market Insights (FMI) in a new study has forecast the global pharmaceutical intermediates market to reach US$ 30 Bn in 2020, with the market predicted to exhibit a CAGR of 4% during the forecast period (2020-2030). The rapidly increasing prevalence of chronic diseases around the world is expected to fuel the need for novel drugs and better treatment option would further drive the growth of the global market. Due to increasing demand for novel drugs option, there has been rising applications of drug intermediates and growing adoption and in the field of research and clinical studies. Leading players in the biotechnology and pharmaceutical sectors along with research institutes are now increasingly focusing on R&D activities relating to drug creation and development. Get a Sample Copy of Report –  https://www.futuremarketinsights.com/reports/sample/rep-gb-4515 Pharmaceutical intermediates are used in during manufacturing of bulk drugs as raw materials. These are the material produced during the synthesis of an active pharmaceutical ingredient (API). However, pharmaceutical and biotech companies can make use of these drug intermediates for the purposes of research and development (R&D). Moreover, there are different forms of pharmaceutical intermediates available such as high quality pharmaceutical intermediates, moderate quality pharmaceutical intermediates and premium quality intermediates. The high-quality and premium pharmaceutical intermediates are mainly used for R&D activities. COVID-19 pandemic is negatively impacting pharmaceutical intermediates sales due to supply chain disruptions caused due to extended period of lockdown. Nonetheless growth is expected to recover because an increasing number of pharma companies are engaging in research and development to find effective treatment and vaccination for COVID-19 virus. Key Takeaways from Pharmaceutical Intermediates Marker Study The demand for chiral intermediates will continue rising through the forecast period East Asia will dominate in the global pharmaceutical intermediates market. China is expected to emerge as the most lucrative market for pharmaceutical intermediates in the region. Analgesics to remain primary application, expanding at Y-o-Y rate exceeding 6% through 2020 The demand for Generic Drug Intermediates is expected to be higher than Branded Drug Intermediates Biotech and Pharma Companies will continue exhibiting high demand for pharmaceutical intermediates Acquisitions, Partnerships and expansion are key Strategic Focus of Pharmaceutical Intermediates Market Players Leading players in the Pharmaceutical Intermediates market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance, On April 2018, strategic collaboration between Porton Pharma Solutions, Ltd. And Codexis, Inc. to use Codexis’ biocatalyst technology within Porton’s global custom active pharmaceutical ingredients (API) and intermediate for manufacturing business. On June 2017, BASF SE is expanding its production capacity at Texas site, whereas it is also constructing new Ibuprofen API facility in Ludwigshafen, Germany, which is expected to be functional in 2021. Key Participant Insights The global market is set to expand its scope in the forecast period, due to rising prevalence of chronic disease globally and adoption of Pharmaceutical Intermediates at various stages of drug development by pharmaceutical manufacturers. In addition to this, cost effectiveness and rise in alternate methods for purification of oligonucleotide has augmented the sales of Pharmaceutical Intermediates. The key market players covered by FMI include Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, Codexis, Lianhe Chemical Technology Co., Ltd, Sanofi S.A, Dishman Group And BASF SE, And Chemcon Speciality Chemicals Pvt. Ltd consolidating their positions through mergers, acquisitions and new product launches. Download PDF Brochure @  https://www.futuremarketinsights.com/reports/brochure/rep-gb-4515   Detailed insights of market segments and sub-segments for historical as well as forecast period   A competitive analysis of prominent players and emerging players in the keyword market   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact Us:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Codexis

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Codexis is included in 2 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

302 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.

A

Advanced Materials

1,221 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.

Codexis Patents

Codexis has filed 460 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • EC 1.1.1
  • RNA
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/17/2020

11/23/2021

Molecular biology, Protein domains, Penicillins, Protein families, Proteins

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/17/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/23/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Protein domains, Penicillins, Protein families, Proteins

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Codexis Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Codexis Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.